Results 191 to 200 of about 292,778 (314)

Mechanism and role of regulated cell death in tumor immunity and immunotherapy

open access: yesCancer Communications, EarlyView.
Abstract Cancer immune checkpoint inhibitors (ICIs) have brought breakthroughs, but only about one‐third of cancer patients benefit from ICIs. In recent years, targeting non‐apoptotic regulated cell death (RCD) subtypes, such as ferroptosis, necroptosis, autophagy, cuproptosis, and pyroptosis, has emerged as a novel strategy in cancer therapy due to ...
Jingwen Hu   +4 more
wiley   +1 more source

Breaking barriers: the cGAS‐STING pathway as a novel frontier in cancer immunotherapy

open access: yesCancer Communications, EarlyView.
Abstract Since its discovery, the cyclic GMP‐AMP synthase (cGAS)‐stimulator of the interferon gene (STING) signaling pathway has been considered a pivotal component of innate immunity and a promising target for cancer immunotherapy. Beyond its canonical role in pathogen defense, accumulating evidence has demonstrated that the cGAS‐STING pathway ...
Yuheng Yan   +5 more
wiley   +1 more source

Advances and challenges in immunotherapy in head and neck cancer. [PDF]

open access: yesFront Immunol
Aboaid H   +9 more
europepmc   +1 more source

Radiation-induced cancers of the head and neck. (III).

open access: bronze, 1989
Katsunori Umatani   +7 more
openalex   +2 more sources

Incidence and Outcomes of Head and Neck Cancer in Patients With Schizophrenia. [PDF]

open access: yesOTO Open
Wenger TA   +8 more
europepmc   +1 more source

Green‐Synthesised Nanoconjugates: Advancing Targeted Photodynamic Therapy for Lung Cancer

open access: yesChemistry &Biodiversity, EarlyView.
ABSTRACT Lung cancer is a type of cancer that develops around the airways or lungs and continues to be the leading cause of cancer‐related deaths worldwide. This has necessitated the need for innovative therapeutic strategies to overcome the limits of existing therapies such as surgery, chemotherapy and radiotherapy.
Njabulo Henry Sibanda   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy